Valeant's outgoing CEO made an insane amount of money last year
.png)
Screenshot/ABC News
It was the year the international giant was brought to its knees.
In October accusations of malfeasance from a short seller combined with government scrutiny over Valeant's drug pricing practices to drag its stock down almost 70%.
Pearson stepped down from the company earlier this month, after it was forced to change its business model, shut down a previously undisclosed internal pharmacy called Philidor, and filed its annual report over a month late, risking defaulting on its $30 billion debt load.
On Wednesday, Pearson, the company's former CFO and billionaire hedge fund investor and board member Bill Ackman testified before Congress, answering for hiking the prices of a number of critical drugs to exhorbitant levels.
Since then the company has also announced that longstanding board members will step down.
New CEO Joe Papa starts on Monday.
NOW WATCH: How ISIS makes over $1 billion a year
Next Story
I spent 2 weeks in India. A highlight was visiting a small mountain town so beautiful it didn't seem real. 
I quit McKinsey after 1.5 years. I was making over $200k but my mental health was shattered.
Some Tesla factory workers realized they were laid off when security scanned their badges and sent them back on shuttles, sources say
Why are so many elite coaches moving to Western countries?
Global GDP to face a 19% decline by 2050 due to climate change, study projects
5 things to keep in mind before taking a personal loan
Markets face heavy fluctuations; settle lower taking downtrend to 4th day
Move over Bollywood, audio shows are starting to enter the coveted ‘100 Crores Club’
